Diagnostics

The latest group of winning technologies has a little something for everyone—from scientists at the lab bench to those in the clinic and even the classroom.

Discover how automation increases the efficiency and reliability of blood-based liquid biopsy assays.

Advanced microscopy aided in the detection of the pathogen responsible for a nationwide superworm apocalypse and informed the development of a potential vaccine strategy.

First-void urine has emerged as a promising sample type for cancer diagnostic test development.

The enjoyment of a good scare may have more to do with relief than terror.

Psilocybin, a psychedelic compound in magic mushrooms, triggers brain activity characteristic of dream states.

Explore how PCR diagnostics support timely detection, targeted treatment, and surveillance of gastrointestinal pathogens.

Advanced diagnostic testing methods empower scientists to swiftly and precisely detect STIs. 

Rare genetic diseases are difficult to diagnose and characterize in the laboratory because of their heterogeneity and global scarcity.

Laboratory experts will share their insights on best practices for working with saliva-derived DNA samples.

Automation, multiplexing, artificial intelligence, and more come together to build a better laboratory environment.  

Data security is a main priority for laboratories handling sensitive patient data and the companies that develop their diagnostic tools. 

Turnkey contract vivarium spaces support novel biotechnology and pharmaceutical discoveries.

Lateral flow tests for COVID-19 can be very accurate and specific when used as directed, but introducing acidic fluids can cause the tests’ detecting antibodies to clump, which may read as a positive result.

User-friendly software connects instruments, consumables, services, and support, reducing manual steps and improving productivity in qPCR workflows.

A novel platform paves the way for genomics-based oncology testing, with a knowledgebase of actionable biomarkers and help for scientists developing in-house tests.

Recombinase polymerase amplification lets researchers rapidly replicate DNA in the clinic, in the field, or even in the International Space Station.

Water impurities affect the operation of clinical analyzers and the accuracy and reproducibility of their results. 

Found circulating in peripheral blood, scientists use cell-free DNA (cfDNA) to assess genetic abnormalities, infections, cancer, transplant rejection, and cardiovascular disease.